 | • レポートコード：B-GIR08C0004 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、アベマシクリブの世界市場について調べ、まとめました。種類別セグメントは、50mgテーブル、100mgテーブル、150mg等、用途別セグメントは、航空宇宙・防衛、医療・ヘルスケア、建築・工学、その他等に区分しました。アベマシクリブの世界市場概観、企業動向、企業別アベマシクリブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・アベマシクリブの市場概観 ・アベマシクリブの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・アベマシクリブの企業別販売動向、市場シェア、市場集中度、競争動向 ・アベマシクリブの世界市場規模 ・アベマシクリブの北米市場分析（アメリカ、カナダ、メキシコ等） ・アベマシクリブのアメリカ市場規模推移 ・アベマシクリブのカナダ市場規模推移 ・アベマシクリブのメキシコ市場規模推移 ・アベマシクリブのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・アベマシクリブのドイツ市場規模推移 ・アベマシクリブのイギリス市場規模推移 ・アベマシクリブのロシア市場規模推移 ・アベマシクリブのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・アベマシクリブの日本市場規模推移 ・アベマシクリブの中国市場規模推移 ・アベマシクリブの韓国市場規模推移 ・アベマシクリブのインド市場規模推移 ・アベマシクリブの東南アジア市場規模推移 ・アベマシクリブの南米市場分析（ブラジル、アルゼンチン等） ・アベマシクリブの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・アベマシクリブの種類別分析/販売量、売上、市場シェア（50mgテーブル、100mgテーブル、150mg） ・アベマシクリブの用途別分析/市場規模（航空宇宙・防衛、医療・ヘルスケア、建築・工学、その他） ・アベマシクリブの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・アベマシクリブの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Abemaciclib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Abemaciclib in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Eli Lilly
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
50mg Tables
100mg Tables
150mg Tables
200mg Tables
Market Segment by Applications, can be divided into
Hospital
Drug Center
Clinic
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Abemaciclib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Abemaciclib, with price, sales, revenue and global market share of Abemaciclib in 2017 and 2018.
Chapter 3, the Abemaciclib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Abemaciclib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Abemaciclib market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Abemaciclib sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Abemaciclib Introduction
1.2 Market Analysis by Type
1.2.1 50mg Tables
1.2.2 100mg Tables
1.2.3 150mg Tables
1.2.4 200mg Tables
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Drug Center
1.3.3 Clinic
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Business Overview
2.1.2 Abemaciclib Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eli Lilly Abemaciclib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Abemaciclib Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Abemaciclib Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Abemaciclib Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Abemaciclib Manufacturer Market Share in 2018
3.3.2 Top 6 Abemaciclib Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Abemaciclib Market Analysis by Regions
4.1 Global Abemaciclib Sales, Revenue and Market Share by Regions
4.1.1 Global Abemaciclib Sales and Market Share by Regions (2014-2019)
4.1.2 Global Abemaciclib Revenue and Market Share by Regions (2014-2019)
4.2 North America Abemaciclib Sales and Growth Rate (2014-2019)
4.3 Europe Abemaciclib Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Abemaciclib Sales and Growth Rate (2014-2019)
4.5 South America Abemaciclib Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Abemaciclib Sales and Growth Rate (2014-2019)
5 North America Abemaciclib by Country
5.1 North America Abemaciclib Sales, Revenue and Market Share by Country
5.1.1 North America Abemaciclib Sales and Market Share by Country (2014-2019)
5.1.2 North America Abemaciclib Revenue and Market Share by Country (2014-2019)
5.2 United States Abemaciclib Sales and Growth Rate (2014-2019)
5.3 Canada Abemaciclib Sales and Growth Rate (2014-2019)
5.4 Mexico Abemaciclib Sales and Growth Rate (2014-2019)
6 Europe Abemaciclib by Country
6.1 Europe Abemaciclib Sales, Revenue and Market Share by Country
6.1.1 Europe Abemaciclib Sales and Market Share by Country (2014-2019)
6.1.2 Europe Abemaciclib Revenue and Market Share by Country (2014-2019)
6.2 Germany Abemaciclib Sales and Growth Rate (2014-2019)
6.3 UK Abemaciclib Sales and Growth Rate (2014-2019)
6.4 France Abemaciclib Sales and Growth Rate (2014-2019)
6.5 Russia Abemaciclib Sales and Growth Rate (2014-2019)
6.6 Italy Abemaciclib Sales and Growth Rate (2014-2019)
7 Asia-Pacific Abemaciclib by Country
7.1 Asia-Pacific Abemaciclib Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Abemaciclib Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Abemaciclib Revenue and Market Share by Country (2014-2019)
7.2 China Abemaciclib Sales and Growth Rate (2014-2019)
7.3 Japan Abemaciclib Sales and Growth Rate (2014-2019)
7.4 Korea Abemaciclib Sales and Growth Rate (2014-2019)
7.5 India Abemaciclib Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Abemaciclib Sales and Growth Rate (2014-2019)
8 South America Abemaciclib by Country
8.1 South America Abemaciclib Sales, Revenue and Market Share by Country
8.1.1 South America Abemaciclib Sales and Market Share by Country (2014-2019)
8.1.2 South America Abemaciclib Revenue and Market Share by Country (2014-2019)
8.2 Brazil Abemaciclib Sales and Growth Rate (2014-2019)
8.3 Argentina Abemaciclib Sales and Growth Rate (2014-2019)
8.4 Colombia Abemaciclib Sales and Growth Rate (2014-2019)
9 Middle East and Africa Abemaciclib by Countries
9.1 Middle East and Africa Abemaciclib Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Abemaciclib Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Abemaciclib Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Abemaciclib Sales and Growth Rate (2014-2019)
9.3 Turkey Abemaciclib Sales and Growth Rate (2014-2019)
9.4 Egypt Abemaciclib Sales and Growth Rate (2014-2019)
9.5 Nigeria Abemaciclib Sales and Growth Rate (2014-2019)
9.6 South Africa Abemaciclib Sales and Growth Rate (2014-2019)
10 Global Abemaciclib Market Segment by Type
10.1 Global Abemaciclib Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Abemaciclib Sales and Market Share by Type (2014-2019)
10.1.2 Global Abemaciclib Revenue and Market Share by Type (2014-2019)
10.2 50mg Tables Sales Growth and Price
10.2.1 Global 50mg Tables Sales Growth (2014-2019)
10.2.2 Global 50mg Tables Price (2014-2019)
10.3 100mg Tables Sales Growth and Price
10.3.1 Global 100mg Tables Sales Growth (2014-2019)
10.3.2 Global 100mg Tables Price (2014-2019)
10.4 150mg Tables Sales Growth and Price
10.4.1 Global 150mg Tables Sales Growth (2014-2019)
10.4.2 Global 150mg Tables Price (2014-2019)
10.5 200mg Tables Sales Growth and Price
10.5.1 Global 200mg Tables Sales Growth (2014-2019)
10.5.2 Global 200mg Tables Price (2014-2019)
11 Global Abemaciclib Market Segment by Application
11.1 Global Abemaciclib Sales Market Share by Application (2014-2019)
11.2 Hospital Sales Growth (2014-2019)
11.3 Drug Center Sales Growth (2014-2019)
11.4 Clinic Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Abemaciclib Market Forecast (2019-2024)
12.1 Global Abemaciclib Sales, Revenue and Growth Rate (2019-2024)
12.2 Abemaciclib Market Forecast by Regions (2019-2024)
12.2.1 North America Abemaciclib Market Forecast (2019-2024)
12.2.2 Europe Abemaciclib Market Forecast (2019-2024)
12.2.3 Asia-Pacific Abemaciclib Market Forecast (2019-2024)
12.2.4 South America Abemaciclib Market Forecast (2019-2024)
12.2.5 Middle East and Africa Abemaciclib Market Forecast (2019-2024)
12.3 Abemaciclib Market Forecast by Type (2019-2024)
12.3.1 Global Abemaciclib Sales Forecast by Type (2019-2024)
12.3.2 Global Abemaciclib Market Share Forecast by Type (2019-2024)
12.4 Abemaciclib Market Forecast by Application (2019-2024)
12.4.1 Global Abemaciclib Sales Forecast by Application (2019-2024)
12.4.2 Global Abemaciclib Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Abemaciclib Picture
Table Product Specifications of Abemaciclib
Figure Global Sales Market Share of Abemaciclib by Types in 2018
Table Abemaciclib Types for Major Manufacturers
Figure 50mg Tables Picture
Figure 100mg Tables Picture
Figure 150mg Tables Picture
Figure 200mg Tables Picture
Figure Abemaciclib Sales Market Share by Applications in 2018
Figure Hospital Picture
Figure Drug Center Picture
Figure Clinic Picture
Figure Other Picture
Figure United States Abemaciclib Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Abemaciclib Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Abemaciclib Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Abemaciclib Revenue (Value) and Growth Rate (2014-2024)
Figure France Abemaciclib Revenue (Value) and Growth Rate (2014-2024)
Figure UK Abemaciclib Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Abemaciclib Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Abemaciclib Revenue (Value) and Growth Rate (2014-2024)
Figure China Abemaciclib Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Abemaciclib Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Abemaciclib Revenue (Value) and Growth Rate (2014-2024)
Figure India Abemaciclib Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Abemaciclib Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Abemaciclib Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Abemaciclib Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Abemaciclib Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Abemaciclib Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Abemaciclib Revenue (Value) and Growth Rate (2014-2024)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Abemaciclib Type and Applications
Table Eli Lilly Abemaciclib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Abemaciclib Sales by Manufacturer (2017-2018)
Figure Global Abemaciclib Sales Market Share by Manufacturer in 2017
Figure Global Abemaciclib Sales Market Share by Manufacturer in 2018
Table Global Abemaciclib Revenue by Manufacturer (2017-2018)
Figure Global Abemaciclib Revenue Market Share by Manufacturer in 2017
Figure Global Abemaciclib Revenue Market Share by Manufacturer in 2018
Figure Top 3 Abemaciclib Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Abemaciclib Manufacturer (Revenue) Market Share in 2018
Figure Global Abemaciclib Sales and Growth Rate (2014-2019)
Figure Global Abemaciclib Revenue and Growth Rate (2014-2019)
Table Global Abemaciclib Sales by Regions (2014-2019)
Table Global Abemaciclib Sales Market Share by Regions (2014-2019)
Table Global Abemaciclib Revenue by Regions (2014-2019)
Figure Global Abemaciclib Revenue Market Share by Regions (2014-2019)
Figure Global Abemaciclib Revenue Market Share by Regions in 2018
Figure North America Abemaciclib Sales and Growth Rate (2014-2019)
Figure Europe Abemaciclib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Abemaciclib Sales and Growth Rate (2014-2019)
Figure South America Abemaciclib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Abemaciclib Sales and Growth Rate (2014-2019)
Figure North America Abemaciclib Revenue and Growth Rate (2014-2019)
Table North America Abemaciclib Sales by Countries (2014-2019)
Table North America Abemaciclib Sales Market Share by Countries (2014-2019)
Figure North America Abemaciclib Sales Market Share by Countries (2014-2019)
Figure North America Abemaciclib Sales Market Share by Countries in 2018
Table North America Abemaciclib Revenue by Countries (2014-2019)
Table North America Abemaciclib Revenue Market Share by Countries (2014-2019)
Figure North America Abemaciclib Revenue Market Share by Countries (2014-2019)
Figure North America Abemaciclib Revenue Market Share by Countries in 2018
Figure United States Abemaciclib Sales and Growth Rate (2014-2019)
Figure Canada Abemaciclib Sales and Growth Rate (2014-2019)
Figure Mexico Abemaciclib Sales and Growth Rate (2014-2019)
Figure Europe Abemaciclib Revenue and Growth Rate (2014-2019)
Table Europe Abemaciclib Sales by Countries (2014-2019)
Table Europe Abemaciclib Sales Market Share by Countries (2014-2019)
Table Europe Abemaciclib Revenue by Countries (2014-2019)
Figure Europe Abemaciclib Revenue Market Share by Countries (2014-2019)
Figure Europe Abemaciclib Revenue Market Share by Countries in 2018
Figure Germany Abemaciclib Sales and Growth Rate (2014-2019)
Figure UK Abemaciclib Sales and Growth Rate (2014-2019)
Figure France Abemaciclib Sales and Growth Rate (2014-2019)
Figure Russia Abemaciclib Sales and Growth Rate (2014-2019)
Figure Italy Abemaciclib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Abemaciclib Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Abemaciclib Sales by Countries (2014-2019)
Table Asia-Pacific Abemaciclib Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Abemaciclib Sales Market Share by Countries 2018
Table Asia-Pacific Abemaciclib Revenue by Countries (2014-2019)
Figure Asia-Pacific Abemaciclib Revenue Market Share by Countries 2018
Figure China Abemaciclib Sales and Growth Rate (2014-2019)
Figure Japan Abemaciclib Sales and Growth Rate (2014-2019)
Figure Korea Abemaciclib Sales and Growth Rate (2014-2019)
Figure India Abemaciclib Sales and Growth Rate (2014-2019)
Figure Southeast Asia Abemaciclib Sales and Growth Rate (2014-2019)
Figure South America Abemaciclib Revenue and Growth Rate (2014-2019)
Table South America Abemaciclib Sales by Countries (2014-2019)
Table South America Abemaciclib Sales Market Share by Countries (2014-2019)
Figure South America Abemaciclib Sales Market Share by Countries in 2018
Table South America Abemaciclib Revenue by Countries (2014-2019)
Table South America Abemaciclib Revenue Market Share by Countries (2014-2019)
Figure South America Abemaciclib Revenue Market Share by Countries in 2018
Figure Brazil Abemaciclib Sales and Growth Rate (2014-2019)
Figure Argentina Abemaciclib Sales and Growth Rate (2014-2019)
Figure Colombia Abemaciclib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Abemaciclib Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Abemaciclib Sales by Countries (2014-2019)
Table Middle East and Africa Abemaciclib Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Abemaciclib Sales Market Share by Countries in 2018
Table Middle East and Africa Abemaciclib Revenue by Countries (2014-2019)
Table Middle East and Africa Abemaciclib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Abemaciclib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Abemaciclib Revenue Market Share by Countries in 2018
Figure Saudi Arabia Abemaciclib Sales and Growth Rate (2014-2019)
Figure UAE Abemaciclib Sales and Growth Rate (2014-2019)
Figure Egypt Abemaciclib Sales and Growth Rate (2014-2019)
Figure Nigeria Abemaciclib Sales and Growth Rate (2014-2019)
Figure South Africa Abemaciclib Sales and Growth Rate (2014-2019)
Table Global Abemaciclib Sales by Type (2014-2019)
Table Global Abemaciclib Sales Share by Type (2014-2019)
Table Global Abemaciclib Revenue by Type (2014-2019)
Table Global Abemaciclib Revenue Share by Type (2014-2019)
Figure Global 50mg Tables Sales Growth (2014-2019)
Figure Global 50mg Tables Price (2014-2019)
Figure Global 100mg Tables Sales Growth (2014-2019)
Figure Global 100mg Tables Price (2014-2019)
Figure Global 150mg Tables Sales Growth (2014-2019)
Figure Global 150mg Tables Price (2014-2019)
Figure Global 200mg Tables Sales Growth (2014-2019)
Figure Global 200mg Tables Price (2014-2019)
Table Global Abemaciclib Sales by Application (2014-2019)
Table Global Abemaciclib Sales Share by Application (2014-2019)
Figure Global Drug Center Sales Growth (2014-2019)
Figure Global Clinic Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Abemaciclib Sales, Revenue and Growth Rate (2019-2024)
Table Global Abemaciclib Sales Forecast by Regions (2019-2024)
Table Global Abemaciclib Market Share Forecast by Regions (2019-2024)
Figure North America Sales Abemaciclib Market Forecast (2019-2024)
Figure Europe Sales Abemaciclib Market Forecast (2019-2024)
Figure Asia-Pacific Sales Abemaciclib Market Forecast (2019-2024)
Figure South America Sales Abemaciclib Market Forecast (2019-2024)
Figure Middle East and Africa Sales Abemaciclib Market Forecast (2019-2024)
Table Global Abemaciclib Sales Forecast by Type (2019-2024)
Table Global Abemaciclib Market Share Forecast by Type (2019-2024)
Table Global Abemaciclib Sales Forecast by Application (2019-2024)
Table Global Abemaciclib Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
ニネタニブの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Nintedanib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Nintedanib in global market,…- シルツキシマブの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Siltuximab is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Siltuximab in global market,…
- アファチニブの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Afatinib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Afatinib in global market, esp…
- ドルテグラビル/リルピビリン配合薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Dolutegravir/Rilpivirine Combination Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on t…
- ドルテグラビル及び併用薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Dolutegravir and Its Combination Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especial…